Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival of < 10% because of diffuse symptoms leading to late-stage diagnosis. That survival could increase significantly if localized tumors could be detected early. Therefore, we used multiparametric analysis o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Mellby, Linda D., Nyberg, Andreas P., Johansen, Julia S., Wingren, Christer, Nordestgaard, Børge G., Bojesen, Stig E., Mitchell, Breeana L., Sheppard, Brett C., Sears, Rosalie C., Borrebaeck, Carl A.K.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2018
Témata:
Biology of Neoplasia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161836/
https://ncbi.nlm.nih.gov/pubmed/30106639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.77.6658
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky